|
|
|
41
|
0603B
|
FLUOROURACIL 50MG/ML INJ (DIL) (BQ)
|
FLUOROURACIL
|
FLUOROURACIL
|
10X10ML
|
BQ
|
126.97
|
12.6973
|
VIAL
|
0
|
BOX
|
DIL
|
FRESENIUS KABI
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
1000
|
ANTINEOPLASTICS
|
2024-04-01
|
2026-03-31
|
|
IV
|
0
|
ANTINEOPLASTICS
|
|
|
|
|
40
|
1103E
|
PROPRANOLOL 1MG/ML INJ (DIL/AHI)
|
PROPRANOLOL
|
PROPRANOLOL
|
10X1ML
|
BQ
|
135.37
|
13.54
|
INJECTION
|
0
|
AMP
|
DIL
|
FRESENIUS KABI
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
2424
|
BETA ADRENERGIC BLOCKING AGENTS
|
2022-04-01
|
2024-03-31
|
|
IV
|
0
|
CARDIOVASCULAR DRUGS
|
|
|
|
|
41
|
1103E
|
PROPRANOLOL 1MG/ML INJ (DIL)
|
PROPRANOLOL
|
PROPRANOLOL
|
10X1ML
|
BQ
|
135.37
|
13.5372
|
AMP
|
30
|
BOX
|
DIL
|
FRESENIUS KABI
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
2424
|
BETA ADRENERGIC BLOCKING AGENTS
|
2024-04-01
|
2026-03-31
|
|
IV
|
0
|
BETA ADRENERGIC BLOCKING AGENTS
|
|
|
|
|
41
|
1163K
|
HYDRALLAZINE 20MG/ML INJ (DIL) (B)
|
HYDRALLAZINE
|
HYDRALLAZINE
|
25X1ML
|
B
|
938.75
|
37.5498
|
VIAL
|
0
|
BOX
|
DIL
|
FRESENIUS KABI
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
240820
|
DIRECT VASODILATOR
|
2024-04-01
|
2026-03-31
|
|
IV
|
0
|
DIRECT VASODILATOR
|
|
|
|
|
40
|
1611N
|
DOCETAXEL 20MG INJ (DIL/AHI)
|
DOCETAXEL
|
DOCETAXEL
|
20MG VIAL
|
C
|
36.02
|
36.02
|
INJECTION
|
0
|
VIAL
|
DIL
|
FRESENIUS KABI
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
1000
|
ANTINEOPLASTICS
|
2022-04-01
|
2024-03-31
|
|
IV
|
0
|
ANTINEOPLASTICS
|
|
|
|
|
40
|
2592AD
|
FAMOTIDINE 10MG/ML INJ (DIL/AHI)
|
FAMOTIDINE
|
FAMOTIDINE
|
25X2ML
|
B
|
120.97
|
4.84
|
INJECTION
|
0
|
AMP
|
DIL
|
FRESENIUS KABI
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
562812
|
HISTAMINE RECEPTOR ANTAGONIST
|
2022-04-01
|
2024-03-31
|
|
IV
|
0
|
GASTROINTESTINAL DRUGS
|
|
|
|
|
41
|
39648
|
SODIUM VALPROATE 100MG/ML INJ (DIL) (B)
|
SODIUM VALPROATE
|
SODIUM VALPROATE
|
10X5ML
|
B
|
142.66
|
14.2658
|
VIAL
|
0
|
BOX
|
DIL
|
FRESENIUS KABI
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
281292
|
ANTICONVULSANTS MISCELLANEOUS
|
2024-04-01
|
2026-03-31
|
|
IV
|
0
|
ANTICONVULSANTS MISCELLANEOUS
|
|
|
|
|
40
|
4021C
|
AZITHROMYCIN 500MG INJ (DIL/AHI)
|
AZITHROMYCIN
|
AZITHROMYCIN
|
10X500MG
|
BQ
|
403.83
|
40.38
|
INJECTION
|
0
|
VIAL
|
DIL
|
FRESENIUS KABI
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
08121292
|
OTHER MACROLIDES
|
2022-04-01
|
2022-09-30
|
|
IV
|
0
|
ANTI-INFECTIVE AGENTS
|
2022-03-29
|
|
|
|
40
|
4222G
|
ACETYLCYSTEINE 20% SOLN (DIL/AHI)
|
ACETYLCYSTEINE
|
ACETYLCYSTEINE
|
3X30ML
|
BQ
|
273.82
|
91.27
|
SOLUTION
|
0
|
VIAL
|
DIL
|
FRESENIUS KABI
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
9212
|
ANTIDOTES
|
2022-04-01
|
2024-03-31
|
|
IV
|
0
|
UNCLASSIFIED THERAPEUTIC AGENTS
|
|
|
|
|
41
|
5422G
|
TOBRAMYCIN 40MG/ML INJ (DIL) (BQ)
|
TOBRAMYCIN
|
TOBRAMYCIN
|
25X2ML
|
BQ
|
482.39
|
19.2958
|
VIAL
|
0
|
BOX
|
DIL
|
FRESENIUS KABI
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
081202
|
AMINOGLYCOSIDES
|
2024-04-01
|
2026-03-31
|
|
IV
|
0
|
AMINOGLYCOSIDES
|
|
|
|
|
40
|
55511
|
THALIDOMIDE 50MG CAP (DIL/AHI)
|
THALIDOMIDE
|
THALIDOMIDE
|
30'S
|
C
|
62.25
|
2.08
|
CAPSULE
|
0
|
CAP
|
DIL
|
FRESENIUS KABI
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
9220
|
BIOLOGIC RESPONSE MODIFIER
|
2022-04-01
|
2024-03-31
|
|
Oral
|
0
|
UNCLASSIFIED THERAPEUTIC AGENTS
|
|
|
|
|
42
|
55511
|
THALIDOMIDE 50MG CAP (DIL)
|
THALIDOMIDE
|
THALIDOMIDE
|
30'S
|
C
|
48.11
|
1.60
|
CAP
|
0
|
BLIS
|
DIL
|
FRESENIUS KABI
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
9220
|
BIOLOGIC RESPONSE MODIFIER
|
2026-04-01
|
|
|
ORAL
|
0
|
BIOLOGIC RESPONSE MODIFIER
|
|
|
|
|
40
|
55521
|
THALIDOMIDE 100MG CAP (DIL/AHI)
|
THALIDOMIDE
|
THALIDOMIDE
|
30'S
|
C
|
110.50
|
3.68
|
CAPSULE
|
0
|
CAP
|
DIL
|
FRESENIUS KABI
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
9220
|
BIOLOGIC RESPONSE MODIFIER
|
2022-04-01
|
2024-03-31
|
|
Oral
|
0
|
UNCLASSIFIED THERAPEUTIC AGENTS
|
|
|
|
|
42
|
55521
|
THALIX 100MG CAP (DIL) THALIDOMIDE
|
THALIDOMIDE
|
THALIX
|
30'S
|
C
|
60.18
|
2.01
|
CAP
|
0
|
BLIS
|
DIL
|
FRESENIUS KABI
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
9220
|
BIOLOGIC RESPONSE MODIFIER
|
2026-04-01
|
|
|
ORAL
|
0
|
BIOLOGIC RESPONSE MODIFIER
|
|
|
|
|
40
|
65216
|
PENTAMIDINE 300MG INJ (DIL/AHI)
|
PENTAMIDINE
|
PENTAMIDINE
|
10X15ML
|
C
|
6,415.24
|
641.52
|
INJECTION
|
0
|
VIAL
|
DIL
|
FRESENIUS KABI
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
083092
|
ANTIPROTOZOALS, MISCELLANEOUS
|
2022-04-01
|
2024-03-31
|
|
IV
|
0
|
ANTI-INFECTIVE AGENTS
|
|
|
|
|
41
|
7093F
|
CARBOPLATIN 450MG INJ (DIL) (BQ)
|
CARBOPLATIN
|
CARBOPLATIN
|
450MG VIAL
|
BQ
|
91.58
|
91.5803
|
VIAL
|
10
|
VIAL
|
DIL
|
FRESENIUS KABI
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
1000
|
ANTINEOPLASTICS
|
2024-04-01
|
2026-03-31
|
|
IV
|
0
|
ANTINEOPLASTICS
|
|
|
|
|
40
|
7111R
|
CISPLATIN 1MG/ML INJ (DIL/AHI)
|
CISPLATIN
|
CISPLATIN
|
50ML
|
BQ
|
18.02
|
18.02
|
INJECTION
|
0
|
VIAL
|
DIL
|
FRESENIUS KABI
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
1000
|
ANTINEOPLASTICS
|
2022-04-01
|
2024-03-31
|
|
IV
|
0
|
ANTINEOPLASTICS
|
|
|
|
|
40
|
71214
|
FLUMAZENIL 0.1MG/ML INJ (DIL/AHI)
|
FLUMAZENIL
|
FLUMAZENIL
|
10X5ML
|
B
|
180.66
|
18.07
|
INJECTION
|
0
|
VIAL
|
DIL
|
FRESENIUS KABI
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
2892
|
CENTRAL NERVOUS SYSTEM AGENTS, MISCELLANEOUS
|
2022-04-01
|
2024-03-31
|
|
IV
|
0
|
CENTRAL NERVOUS SYSTEM DRUGS
|
|
|
|
|
40
|
A591AA
|
DOXORUBICIN 50MG SOLN FOR INJ (DIL/AHI)
|
DOXORUBICIN
|
DOXORUBICIN
|
50MG VIAL
|
BQ
|
25.91
|
25.91
|
SOLUTION FOR
|
0
|
VIAL
|
DIL
|
FRESENIUS KABI
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
1000
|
ANTINEOPLASTICS
|
2022-04-01
|
2024-03-31
|
|
IV
|
0
|
ANTINEOPLASTICS
|
|
|
|
|
40
|
A751D
|
OCTREOTIDE 0.1MG/ML INJ (DIL/AHI)
|
OCTREOTIDE
|
OCTREOTIDE
|
10X1ML
|
BQ
|
24.55
|
2.46
|
INJECTION
|
0
|
VIAL
|
DIL
|
FRESENIUS KABI
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
9292
|
OTHER THERAPEUTIC AGENTS
|
2022-04-01
|
2024-03-31
|
|
IV
|
0
|
UNCLASSIFIED THERAPEUTIC AGENTS
|
|
